Tech Company Financing Transactions
ArkeaBio Funding Round
On 10/1/2026, ArkeaBio secured $7 million in Series A financing from AgriZeroNZ, Breakthrough Energy Ventures and private investors.
Transaction Overview
Company Name
Announced On
10/1/2026
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series A
Investors
AgriZeroNZ (Lead Investor) (Wayne McNee)
Breakthrough Energy Ventures (Lead Investor) (Chris Rivest)
Proceeds Purpose
The company intends to use the funds to support continued R&D, farmer pilot programs, and general operations.
Company Information
Company Status
Private & Independent
Industry
AgTech
Mailing Address
Undisclosed
Reno, NV 89519
USA
Reno, NV 89519
USA
Phone
Undisclosed
Website
Email Address
Overview
ArkeaBio is using innovative vaccine technologies to create solutions to reduce the on-farm methane emissions responsible for 6% of global GHG emissions. ArkeaBio technology will be integrated into proven delivery systems and farming practices to safely reduce global methane emissions from multiple ruminant species across a variety of geographies and agronomic systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Colin South
Vice President
Matthew Dunn
Browse more venture capital transactions:
Prev: 10/1/2026: ElevenLabs venture capital transaction
Next: 10/1/2026: Armadin venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs